US-based virtual care app developer Conversa Health has picked up $8m of extra funding to close its $20m series B round co-led by Northwell Ventures, a corporate venturing unit of healthcare provider Northwell Health.
Venture capital firm Builders VC also co-led the round which increased Conversa’s total funding to $34m.
The company expanded the round from $12m to $20m, after holding an initial close in June last year, with participation from hospital operator University Hospitals’ strategic investment arm UH Ventures and venture capital firms P5 Health Ventures and Nassau Street Ventures.
VC firms Genesis Merchant Capital, J-Ventures, Epic Ventures and StartUp Health have also backed the round.
Conversa will use the additional series B funds to continue to scale its technology platform and expand its library of automated virtual care digital pathways, the company said.
Michael Dowling, president and CEO of Northwell Health, said: “Conversa has become a critical collaborator in achieving our vision for virtual health, helping Northwell to engage, monitor and manage patients more efficiently than ever before.”
Conversa was founded in 2014 and has developed a mobile app that enables healthcare providers to virtually monitor and manage their patients. The platform can also provide virtual consultations based on medical data and electronic health records.
Conversa pulled in $2.5m of seed funding from unnamed investors in 2015, before raising an undisclosed amount from investors including Social Venture Fund the following year.
Northwell Ventures led a $8m series A round for Conversa in 2017, that included healthcare provision database Healthgrades, Epic Ventures and undisclosed existing investors.